Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

VEGFR inhibitors and their use in psoriasis and other disorders

Dec. 16, 2002

IL-15-targeting antibody superior to ciclosporin in mouse model of psoriasis

Dec. 10, 2002

Efalizumab suppresses inflammation-related genes in addition to T-cell migration

Dec. 10, 2002

Orphan drug status sought for thymosin beta 4

Dec. 10, 2002

Induction of Th2 responses reported for rhIL-4 in psoriatic patients

Dec. 10, 2002

Potential use of NO-releasing hydrogel dressing in wound healing

Dec. 10, 2002

Novel glucocorticoids in early development at GSK

Dec. 4, 2002

New data on a fixed combination of calcipotriol/betamethasone dipropionate in psoriasis

Dec. 2, 2002

T-cell depletion by alefacept reported effective in psoriatic lesions

Dec. 2, 2002

GAM product evaluated in phase I trial for diabetic foot ulcers

Nov. 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...